Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2285)	3/17/2008 1:58:34 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

CRME is up another 36% in spite of the general market. bigcharts.marketwatch.com It announced today positive results from its 90-day PII2b of oral vernakalant. The drug was also was well tolerated in the atrial fibrillation patients. The stock is starting to get off from the DT coming from its Nov H at $12.62 It has further resistance from its Sep 2006 H at $14.06 & after that it should be ready to test its Jan 2006 all time H at $14.45 <g> bigcharts.marketwatch.com Bernard